PURPOSE: The aim of this study is to search for new therapeutic targets for atypical teratoid-rhabdoid tumors (ATRT). METHODS: To achieve this, we compared the expression of 365 microRNAs among ATRT, medulloblastomas, and normal brain. RESULTS: MiR-221 and miR-222 were within the top differentially expressed microRNAs. The deregulated expression of miR221/222 was demonstrated to inhibit the expression of the tumor suppressor and inhibitor of cell cycle p27(Kip1). Here, we demonstrated the negative regulation of p27(Kip1) by miR-221/222 in ATRT using microarray, real-time reverse transcriptase polymerase chain reaction, and immunohistochemistry. CONCLUSION: As anti-miR therapy was recently proposed as an alternative treatment for cancer, these findings suggest that anti-miR-221/222 therapy might have therapeutic potential in ATRT.
PURPOSE: The aim of this study is to search for new therapeutic targets for atypical teratoid-rhabdoid tumors (ATRT). METHODS: To achieve this, we compared the expression of 365 microRNAs among ATRT, medulloblastomas, and normal brain. RESULTS:MiR-221 and miR-222 were within the top differentially expressed microRNAs. The deregulated expression of miR221/222 was demonstrated to inhibit the expression of the tumor suppressor and inhibitor of cell cycle p27(Kip1). Here, we demonstrated the negative regulation of p27(Kip1) by miR-221/222 in ATRT using microarray, real-time reverse transcriptase polymerase chain reaction, and immunohistochemistry. CONCLUSION: As anti-miR therapy was recently proposed as an alternative treatment for cancer, these findings suggest that anti-miR-221/222 therapy might have therapeutic potential in ATRT.
Authors: S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace Journal: Biochem Biophys Res Commun Date: 2005-09-09 Impact factor: 3.575
Authors: V Oyharcabal-Bourden; C Kalifa; J C Gentet; D Frappaz; C Edan; P Chastagner; E Sariban; A Pagnier; A Babin; F Pichon; S Neuenschwander; M Vinchon; D Bours; V Mosseri; C Le Gales; M Ruchoux; C Carrie; F Doz Journal: J Clin Oncol Date: 2005-07-20 Impact factor: 44.544
Authors: Susan N Chi; Mary Ann Zimmerman; Xiaopan Yao; Kenneth J Cohen; Peter Burger; Jaclyn A Biegel; Lucy B Rorke-Adams; Michael J Fisher; Anna Janss; Claire Mazewski; Stewart Goldman; Peter E Manley; Daniel C Bowers; Anne Bendel; Joshua Rubin; Christopher D Turner; Karen J Marcus; Liliana Goumnerova; Nicole J Ullrich; Mark W Kieran Journal: J Clin Oncol Date: 2008-12-08 Impact factor: 44.544
Authors: Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler Journal: Nucleic Acids Res Date: 2005-11-27 Impact factor: 16.971
Authors: Neri Mercatelli; Valeria Coppola; Desirée Bonci; Francesca Miele; Arianna Costantini; Marco Guadagnoli; Elena Bonanno; Giovanni Muto; Giovanni Vanni Frajese; Ruggero De Maria; Luigi Giusto Spagnoli; Maria Giulia Farace; Silvia Anna Ciafrè Journal: PLoS One Date: 2008-12-24 Impact factor: 3.240
Authors: Jill Samis; Elio F Vanin; Simone Treiger Sredni; Maria de Fátima de Bonaldo; Fabricio F Costa; Tadanori Tomita; Reema Habiby; Donald Zimmerman; Marcelo B Soares Journal: Childs Nerv Syst Date: 2016-06-07 Impact factor: 1.475
Authors: Jan Laco; Helena Kovaříková; Marcela Chmelařová; Hana Vošmiková; Kateřina Sieglová; Ivana Baranová; Pavel Dundr; Kristýna Němejcová; Jaroslav Michálek; Jana Šatanková; Milan Vošmik; Aleš Ryška Journal: Virchows Arch Date: 2018-01-11 Impact factor: 4.064
Authors: C Quintavalle; M Garofalo; C Zanca; G Romano; M Iaboni; M del Basso De Caro; J C Martinez-Montero; M Incoronato; G Nuovo; C M Croce; G Condorelli Journal: Oncogene Date: 2011-07-11 Impact factor: 9.867
Authors: Simone Treiger Sredni; Abby L Halpern; Christopher A Hamm; Maria de Fátima Bonaldo; Tadanori Tomita Journal: Childs Nerv Syst Date: 2012-11-10 Impact factor: 1.475
Authors: Zhiguang Li; William S Branham; Stacey L Dial; Yexun Wang; Lei Guo; Leming Shi; Tao Chen Journal: BMC Genomics Date: 2010-10-28 Impact factor: 3.969